Posted by Two Blokes
FedEx forecast a worse-than-expected profit for the current quarter and said it would only share its outlook f
Source: Two Blokes Trading
Posted by Two Blokes
The XRP price has five days left to break a stubborn losing streak that has lasted since 2018. So far, June 20
Source: Two Blokes Trading
Posted by Two Blokes
Cites Continued Failure to Perform Fiduciary Duty by GIPR Management and Board of Directors Cites Continued Fa
Source: Two Blokes Trading
Posted by Two Blokes
Yieldmax MSTR Option Income Strategy ETF's headline ~100%+ yield is mostly return of capital, not sustainable
Source: Two Blokes Trading
Posted by Two Blokes
As geopolitical developments continue to impact global markets, the cryptocurrency space remains highly reacti
Source: Two Blokes Trading
Posted by Two Blokes
TOST and LSPD compete head-to-head in the hospitality tech space, making them key rivals in the booming POS ma
Source: Two Blokes Trading
Posted by Two Blokes
VZ lands a multibillion-dollar deal to deploy Private 5G across the Thames Estuary, transforming key U.K. logi
Source: Two Blokes Trading
Posted by Two Blokes
CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gai
Source: Two Blokes Trading
Posted by Two Blokes
GE HealthCare gains FDA nod to expand Vizamyl's use, unlocking new diagnostic and therapy-monitoring capabilit
Source: Two Blokes Trading
Posted by Two Blokes
BrightSpring boosts 2025 guidance as Pharmacy and Provider segments post strong gains and margin initiatives t
Source: Two Blokes Trading
Posted by Two Blokes
Sanofi's riliprubart gets FDA orphan drug status for organ transplant rejection, unlocking key development per
Source: Two Blokes Trading
Posted by Two Blokes
BMY depends on Reblozyl, Opdualag and Breyanzi to offset revenue hits from generics and Medicare Part D impact
Source: Two Blokes Trading